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Abstract
Purpose: Survivorship care plans (SCPs) have been suggested
to reduce fragmentation of care experienced by cancer survi-
vors. Acceptance of SCPs is high, but trials in the United States
are few. This pilot study used a quasiexperimental design to
examine the outcomes achieved by breast cancer survivors re-
ceiving a standardized SCP visit at one of seven comprehensive
cancer centers.
Materials and Methods: Outcomes were assessed before
and again 3 months after delivery of an SCP and included survi-
vors’ use of and satisfaction with SCPs, perceived knowledge
about survivorship, and assessment of the quality and coordina-
tion of survivorship care.
Results: One hundred thirty-nine survivors of breast cancer
completed baseline and follow-up measures and received a
standardized SCP visit. Participants most commonly used SCP
materials to make decisions about exercise (64%), which tests to
receive and when (62%), and dietary changes (62%). Only 21%
shared the SCP with their primary care provider during that time.
Satisfaction with the SCP was high, with 90% of participants
reporting being at least satisfied with the SCP. Perceived knowl-
edge about survivorship improved after SCP delivery, as did
perceived care coordination and the provider’s knowledge of the
effects of cancer on survivors (all P  .001). Individuals closer to
the time of diagnosis reported greater satisfaction with and use
of SCPs.
Conclusion: This study demonstrates improvements in per-
ceived knowledge and quality of survivorship care after receipt of
a comprehensive SCP. Survivors were satisfied with their SCP,
and those closer to diagnosis reported greater satisfaction with
and use of the materials.
Introduction
Survivorship care plans (SCPs) have been suggested as a possible
means to reduce fragmentation of care and suboptimal out-
comes experienced by the more than 14 million US cancer
survivors.1 Provider and patient acceptance of SCPs is high, but
trials have primarily examined outcomes such as cancer-related
distress rather than constructs related to the purpose of SCPs,
such as improving care coordination and patient knowledge.
Moreover, the largest trial2 took place in Canada, where care is
generally less fragmented, limiting generalizability.3
An Institute of Medicine (IOM) report4 identified four
components of survivorship care as essential: prevention and
detection of cancer, cancer surveillance, intervention for
long-term/late effects, and coordination of care between
providers. One attempt to meet these recommendations is to
present patients with a summary of their disease and treat-
ment history (TS) to guide future care outlined in a fol-
low-up plan, together known as the SCP. Although general
in nature, the IOM recommends that these plans provide
information regarding potential toxicities and late effects,
cancer and noncancer surveillance, signs and symptoms of
cancer, psychosocial effects, needed referrals, prevention and
health promotion, recommendations for genetic testing, and
familial cancer risk.5
At the time of the IOM report, the assumption was that SCPs
would improve follow-up care and patient outcomes. However,
almost 9 years later, cancer centers continue to struggle with im-
plementation barriers including reimbursement issues, institu-
tional resources, and the time required to personalize an SCP.6-8
Despite acknowledgment by professional groups that survivorship
should be part of the continuum of cancer care, there remains a
lack of evidence-based surveillance guidelines for adult survivors.9
Moreover, there are few data concerning the benefits of SCPs,10-13
inadequate resources to support integrating SCPs into routine
care, and lack of processes for examining outcomes. Perry et al14
proposed a framework that includes outcomes such as care co-
ordination; however, it remains unclear whether SCPs improve
survivors’ knowledge regarding the effects of treatment,15 and
there remain no data to indicate whether timing of SCP delivery
impacts symptom management, satisfaction, coordination of
care, or knowledge.
Some studies have examined attitudes and preferences for
delivery of follow-up care among patients and providers. There
seems to be a general consensus that survivors and providers are
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open to written SCPs to support shared care, that content needs
to include general information as well as information about
specific disease and treatment exposures, and that these SCPs should
be personalized to the needs and preferences of patients.16-25
Models for delivering care have been examined including dis-
ease-specific and general survivorship clinics, group clinic visits,
telephone outreach, consultative clinic visits, shared care, and
survivorship care integrated into oncology practices.8,26-30 A
variety of care plan templates have been developed31-33; how-
ever, providers and investigators continue to debate which spe-
cifics should be included.14,34-36 Studies that examine SCP
development have focused on identification and management
of symptoms, and resource use6-8 with few studies focused on
patient experiences.17,23,37,38
Despite inadequate data, SCPs are becoming the standard of
care with mandates to comply coming.39 The purpose of this
study was to explore the outcomes associated with delivery of a
comprehensive, standardized SCP to breast cancer survivors.
This pilot study used a quasiexperimental, pretest/post-test de-
sign to examine the outcomes achieved by the survivors at seven
cancer centers and associated community clinics affiliated with
the LIVESTRONG Survivorship Centers of Excellence Net-
work (SCOEN) after a care plan visit. Constructs such as coor-
dination of care, knowledge about survivorship issues, and
perceived usefulness of SCPs by patients were examined.
Materials and Methods
Setting
This project took place within a group of seven National Cancer
Institute–designated comprehensive cancer centers and their com-
munity practices. Participating sites were required to institute a
standardized care visit that included a specified TS and SCP. Prac-
titioners (physician extenders, n  12; physicians, n  2) were
trained in the use of the SCP materials and visit content via tele-
phone and web-based conference training calls. Materials were to
be presented to participants in a standard order, with practitioners
first presenting the TS and discussing the need for coordination of
care with primary and other providers and then presenting the
SCP, focusing on future health and behavioral needs, and finishing
with a presentation of any additional educational materials that
might be of specific assistance to a given survivor. Sites determined
their own procedure for ensuring identification of potential partic-
ipants and completion of materials but were provided with finan-
cial and logistic support for these activities.
Participants
Eligibility included age of 18 years or older, diagnosis and treat-
ment of nonmetastatic breast cancer or ductal carcinoma in
situ, completion of acute cancer therapy, and a scheduled sur-
vivorship visit at the SCOEN site where acute therapy was
administered. Time since diagnosis or end of treatment was not
controlled. Receipt of targeted or hormonal therapy was al-
lowed. Participants unable to complete informed consent be-
cause of language or intellectual difficulties and those who had
previously received an SCP were excluded.
Standardized Care Plan Visit
The visit contained three primary components: the Journey
Forward TS,31 a LIVESTRONG SCP powered by Penn’s On-
colink,32 and educational materials. The TS contains a sum-
mary outlining disease and treatment details, American Society
of Clinical Oncology guidelines for cancer follow-up and sur-
veillance, a list of potential late effects, and a list of resources.4,33
In presenting the TS, providers worked with survivors to iden-
tify specific providers (eg, primary care) responsible for aspects
of survivors’ future health care and encouraged survivors to
share materials with providers. The LIVESTRONG SCP pro-
vides individualized recommendations for surveillance and
health care guidelines. Recommendations reflect evidence or
consensus-based guidelines whenever possible, were developed
with provider input, and were described in plain language. To
ensure that minimum IOM recommendations for content were
met, additional educational materials covered other surveillance
recommendations, legal advice, psychosocial issues, counseling,
exercise, weight loss and healthy weight, diet and nutrition,
immunizations, fatigue, lymphedema, bone loss and osteopo-
rosis, menopausal symptoms, cognitive effects, and genetic test-
ing recommendations. Providers could add to but not remove
materials in the educational packet.
Procedure
After approval by all participating institutions’ institutional re-
view boards, clinic schedules were screened for eligible potential
participants, and participants were approached while checking
in. Participants provided informed consent and completed
baseline instruments in the clinic. In a second recruitment
method, charts were screened before scheduled survivorship
visits, and eligible patients were contacted by phone to invite
participation. Those who agreed received a letter explaining the
study, an informed consent/Health Insurance Portability and
Accountability Act form, baseline questionnaire packet, and an
envelope in which to store materials. Each Participant was asked
to bring the completed packet to her upcoming visit and re-
ceived a reminder call.
Approximately 3 months after the survivorship visit and
baseline measures, participants with internet access were sent an
e-mail asking them to log in to a secure Web site to complete
follow-up measures. Individuals who did not complete online
measures within 1 week received up to three reminder emails
and/or telephone calls before being considered lost to follow-
up. Participants without access to the internet or who preferred
pen-and-paper questionnaires were sent a follow-up question-
naire packet at 3 months. If materials were not returned within
2 weeks, participants received up to three telephone reminder
calls before being considered lost to follow-up.
Measures
Unless otherwise noted, the following measures were designed
by members of the investigator team (S.C.P./C.T.S./L.A.J.)
through literature review, clinical experience, and consensus
(materials available on request).
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Demographics. Demographics included age, race, ethnicity,
marital status, education, current employment, and household
income.
Quality of life. Quality of life was assessed using the Medical
Outcomes Study Short Form (SF) –12.40 The SF-12 is an ex-
tensively validated instrument that has been widely used as an
alternative to the SF-36 and shown to account for more than
90% of the variance in SF-36 summary measures.
Use of SCP materials. A 16-item investigator-developed survey
assessed patient use of SCPs.41 The survey covered use of the
SCPs for seeking information (eg, online searching, question-
ing of providers), behavior change (eg, making changes in diet),
and communication (eg, sharing with a primary care provider).
Satisfaction with SCP. Participants rated global satisfaction
with SCPs on a five-point scale ranging from “extremely unsat-
isfied” to “extremely satisfied.” Satisfaction was also rated using
a newly developed scale indicating degree of agreement with 10
items assessing whether the SCP was useful, informative, and
reassuring on a scale of 0 (“strongly disagree”) to 3 (“strongly
agree”; Cronbach’s alpha  .82).41
Primary outcomes. Perceived coordination of survivorship care
was assessed using a five-item investigator-developed question-
naire. This questionnaire assessed the degree to which patients
agreed with statements that health care providers worked to-
gether to provide quality care in a coordinated fashion (eg, “My
health care providers communicate with one another about my
needs”) on a scale of 0 (“strongly disagree”) to 3 (“strongly
agree”; Cronbach’s alpha  .84).41
Perceived knowledge about survivorship care was assessed
using a newly developed 13-item scale assessing degree of agree-
ment with statements concerning patients’ knowledge of poten-
tial long-term effects of disease and treatment and how to access
follow-up care (eg, “I know which provider is responsible for
ordering screening tests to look for cancers other than breast
cancer”) on a scale of 0 (“strongly disagree”) to 3 (“strongly
agree”; Cronbach’s alpha  .87).41
Perceived provider knowledge was assessed using three items
assessing patient perception of how well follow-up providers
understand their medical history and its impact on their quality
of life on a scale of 0 (“poor”) to 4 (“excellent”; Cronbach’s
alpha  .84).41
Provider behavior was assessed using six items assessing the
frequency with which providers attended to the informational
and supportive needs of participants (eg, “How often did your
provider make sure that you understood all the information he
or she gave you”) on a scale of 0 (“never”) to 3 (“always”;
Cronbach’s alpha  .93).41
Results
Participants
Of 193 women recruited, 139 provided both baseline and
3-month follow-up data (72%). As seen in Table 1, these
women were primarily middle-age, white, married, college
graduates, employed, with incomes of greater than $80,000 per
year. Most had been diagnosed with stage I or II breast cancer at
an average of 3.4 years previous to enrollment. Using the SF-12,
participants at baseline reported mental health that was signif-
icantly higher than normative values (M  54.38; standard
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deviation [SD]  11.19; P  .001) whereas physical health was
significantly lower than normative values (M  47.97; SD 
8.85; P  .01). Quality of life was significantly related to time
since diagnosis for mental health (r  .286; P  .001) but not
for physical health (r  .121; P was not significant).
Those who completed both assessments did not differ sig-
nificantly from those who did not in age, race, marital status,
education, employment status, income, stage at diagnosis, or
SF-12 mental or physical health (all P  .19). There was a
nonsignificant trend among those who did not complete the
assessments to be farther from their initial cancer diagnosis
(M  4.78) than those who completed assessments (M  3.44;
F[1, 191]  3.75; P  .054).
Use of SCP Materials
Table 2 shows self-reported use of SCP materials in the 3-month
postintervention period. More than 96% of participants reported
that they retained their SCP, and 88% said that they read it care-
fully. Overall, participants reported using the SCP in 6.9 (SD 
3.95) different ways. Although most women shared their SCP with
their partner, used it to assist discussion of their cancer experience
with family members, or to help inform family members about
their own cancer risk, less than 25% shared the SCP with their
primary care providers. The most common uses of the SCP were in
the realm of health behaviors such as making decisions about ex-
ercise, diet, and the type/frequency of medical testing. SCPs were
less commonly used to assist in searches for information or re-
sources. There was a small but significant relationship between
total use of SCPs and time since diagnosis (r [138]  .18; P 
.03) with individuals closer to diagnosis reporting greater use.
Satisfaction With SCP Materials
Overall satisfaction with the SCP is shown in Appendix Figure A1
(online only). Approximately 56% reported being “very” or “ex-
tremely satisfied,” whereas only 10% of participants reported being
“unsatisfied.” Satisfaction with SCPs was significantly related to
time since diagnosis (r [138]  .26; P  .002). Examination of
means showed that those who reported being “unsatisfied” were on
average 5.6 years (SD, 5.08 years) from diagnosis whereas those in
the “extremely satisfied” group were an average of 2.6 years (SD,
2.73 years) from diagnosis. Overall satisfaction was moderately
related to total use of SCP materials; those who used the materials
were more satisfied (r  .37; P  .001).
Participants generally agreed that SCPs were useful, infor-
mative, and reassuring (M  2.14 [0.39]). This was unrelated
to time since diagnosis (r  .06; P was not significant), al-
though moderately related to total use of SCPs (r  .47; P 
.001).
Outcomes of the SCP Visit
Table 3 presents means for the pre/post outcome variables.
Overall, participants reported significant increases in perceived
coordination among providers (t  4.15; P  .001). Corre-
lation of change scores with time since diagnosis suggested that
increased coordination was independent of time since diagnosis
(r  .044; P was not significant). Perceived knowledge con-
cerning cancer care increased significantly after the SCP visit
(t  5.09; P  .001). Change in perceived knowledge was
also independent of time since diagnosis (r  .05; P was not
significant). Perceived provider knowledge increased after the
SCP visit (t  2.04; P  .05), independent of time since
diagnosis (r  .12; P was not significant). Finally, perceived
provider behavior produced a nonsignificant trend toward im-
provement (t  1.61; P  .11) independent of time since
diagnosis (r  .07; P was not significant). There were no sig-
nificant differences between SCOEN sites in pre/post change in
any primary outcomes (all F  0.96; all P  .45).
Discussion
SCP delivery will be mandated for the more than 70% of pa-
tients with cancer treated in American College of Surgeons–
accredited centers,39 and this is likely an underestimate given
IOM recommendations.4 Few studies have examined outcomes
of providing SCPs in the United States. Our results suggest that
Table 2. Self-Reported Use of SCP Materials
Reported Use No. %
Read it carefully 121 87.7
Used it to help you decide what kind of exercise to engage
in
89 64.0
Used it to help make changes in what you eat 86 61.9
Used it to help you decide which F/U tests you need and
when
86 61.9
Used it to help communicate concerns to provider 78 56.1
Used it to help you talk about your cancer experience with
family
76 54.7
Used it to inform yourself about symptoms 74 53.2
Shared it with spouse 70 50.4
Used it to help you talk with family members about their risk
for cancer
68 48.9
Used it to help you take action about seeing PCP 64 46.0
Used it to help you make decisions about losing weight 61 43.9
Used it to search for online information 54 38.8
Used it to help you find resources for support 47 33.8
Used it to help find referrals for F/U 34 24.5
Shared it with family members who might be at risk for
cancer
33 23.7
Shared it with PCP 29 20.9
Abbreviations: F/U, follow-up; PCP, primary care provider; SCP, survivorship care
plan.






t PMean SD Mean SD
Coordination of care 2.11 0.49 2.27 0.44 4.15  .001
Knowledge about care 1.76 0.54 1.99 0.42 5.09  .001
Provider knowledge of
cancer’s effects
2.59 1.12 2.77 0.91 2.04  .05
Satisfaction with
provider behavior
2.56 0.61 2.64 0.52 1.61 .11
Abbreviation: SD, standard deviation.
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breast cancer survivors tend to use and be highly satisfied with
SCPs. In the 3 months after SCP receipt, most survivors used
the materials to assist them in making health behavior choices
and to aid in communication with family and providers. Only
approximately one of five participants shared the SCP with
their primary care provider, suggesting that follow-up may have
been too brief for survivors to have had a primary care provider
visit. We examined the rate of sharing SCP materials among
participants who had seen a primary care provider and found a
somewhat higher rate (approximately 38%). In addition, those
closer in time to diagnosis reported greater use and satisfaction
than those for whom more time had elapsed, and greater use
was associated with greater satisfaction. With respect to changes
after receipt of SCPs, patients reported greater belief that their
medical care was coordinated, that their provider was knowl-
edgeable, and that they were knowledgeable about managing
their own survivorship care.
These findings are similar to those of others who found high
satisfaction with SCPs42 and support findings of Kaiser-Hill et al43
that used a prior version of the SCP in a self-selected sample of
diverse patients and a post-test–only design. These survivors also
reported high satisfaction with the information received, that it
assisted them in making health behavior decisions, and that they
planned to use the materials to communicate with their health care
team. Among those who had already used the materials with their
providers, 80% reported that the SCP was helpful in facilitating
communication. This study furthers these results by demonstrat-
ing pre/post changes in behaviors, perceptions of care, and actual
use of materials over a longer period of time in a less self-selected
sample. Moreover, our results suggest that earlier access to SCPs
results in greater changes than later exposure.
These results differ somewhat from those reported by Grunfeld et
al2—satisfaction and perceived coordination of care were either unaf-
fected or slightly decreased at 3 months after an SCP visit, and time
from diagnosis did not influence outcomes. Our data suggested both
an increase in satisfaction/coordination and that those closer to the
timeofdiagnosisexperiencedagreaterchangeacrossseveralconstructs.
This may partly reflect the usual care condition described by Grunfeld
et al, in which participants received a discharge visit and transfer to
primary care, to which the experimental arm added delivery of a writ-
ten SCP. Care of this quality is seldom routine in US hospital systems,
and similaritybetweencontrol andexperimental armsmakes interpre-
tationofnull resultsdifficult to interpret, let alonegeneralize.3 Regard-
less, given the differences between the United States and Canadian
healthcare systems,ourresults suggest thatSCPsmaybemore impact-
ful in more fragmented health care systems.
This work is limited by its quasiexperimental design and should be
seen as suggestive rather than definitive. More sophisticated trials are
needed to confirm results and extend these across time and popula-
tions. Our sample was primarily white and well-educated and received
care at specialized survivorship clinics/visits; these results may not gen-
eralize to other populations or settings. Moreover, many of the mea-
sures were developed specifically for this study or were relatively new.
Although internal consistency was adequate for those measures for
which this is an appropriate metric, these measures will require further
refinementandvalidation.Similarly,giventhat survivorscouldbeseen
for later follow-up care by affiliated or nonaffiliated health care provid-
ers, we relied on self-report rather than chart abstraction to ascertain
follow-up behaviors. Strengths included a well-characterized sample
obtained across a wide variety of cancer care settings, pre/post assess-
ments, high retention, and visits and materials that were standardized
across settings. Moreover, similar results across participating centers
suggest that it is possible to standardize visits and materials across di-
verse settings and providers, and success at all sites in recruitment and
completion suggests that, with institutional commitment and finan-
cial and logistical support, SCPs can be delivered to patients.
In summary, our data suggest that SCPs are valued and used
by breast cancer survivors, particularly among those closer to
diagnosis and treatment, and that there may be a teachable
moment earlier in the survivorship trajectory when survivors are
more open to behavioral change for health promotion.44 SCPs
may also influence perceptions of the coordination of care re-
ceived and knowledge of the transition to survivorship. As man-
dates for the provision of SCPs are made, research focusing on
whether SCPs result in improved health behaviors and out-
comes, reduced burden in care transitions from the oncology
setting, and research on cost-effectiveness will be needed if ef-
forts are to be sustainable.
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Figure A1. Overall satisfaction with survivorship care plans.
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